Protegemos tu salud a través de la Ciencia
Investigación
Unidad de Investigación en Modelos y Mecanismos
Publicaciones destacadas
Identifying data sources for a national population-based registry: the experience of the Spanish Rare Diseases Registry. Public Health. 2015 Mar;129(3):271-5
Zoni AC, Domínguez Berjón MF, Barceló E, Esteban Vasallo MD, Abaitua I, Jiménez Villa J, Margolles Martins M, Navarro C, Posada de la Paz M, Ramos Aceitero JM, Vázquez Santos C, Zurriaga Llorens O, Astray Mochales J; Spain-RDR Group.
PUBMED DOIThe TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015 Apr;36(4):395-402
Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barišić N, Brabec P, Lahdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Viswanathan V, Bayat F, Buccella F, Kimura E, Koeks Z, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Zimowski J, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Jeannet PY, Joncourt F, Díaz-Manera J, Gallardo E, Karaduman AA, Topaloğlu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Bellgard MI, Kirschner J, Flanigan KM, Straub V, Bushby K, Verschuuren J, Aartsma-Rus A, Béroud C, Lochmüller H.
PUBMED DOIOsteochondromas in fibrodysplasia ossificans progressiva: a widespread trait with a streaking but overlooked appearance when arising at femoral bone end. Rheumatol Int. 2015 Oct;35(10):1759-67
Morales-Piga A, Bachiller-Corral J, González-Herranz P, Medrano-SanIldelfonso M, Olmedo-Garzón J, Sánchez-Duffhues G.
PUBMED DOISocial/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:19-29
Cavazza M, Kodra Y, Armeni P, De Santis M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Taruscio D, Schieppati A, Iskrov G, Péntek M, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and health-related quality of life in patients with scleroderma in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:109-17
López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:99-108
López-Bastida J, Linertová R, Oliva-Moreno J, Posada de la Paz M, Serrano-Aguilar P, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Baji P, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and health-related quality of life in patients with histiocytosis in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:67-78
Iskrov G, Astigarraga I, Stefanov R, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Schieppati A, Taruscio D, Péntek M, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and quality of life in patients with haemophilia in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:53-65
Cavazza M, Kodra Y, Armeni P, De Santis M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Taruscio D, Schieppati A, Iskrov G, Gulácsi L, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and health-related quality of life in patients with cystic fibrosis in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:7-18
Chevreul K, Michel M, Brigham KB, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Taruscio D, Schieppati A, Iskrov G, Péntek M, von der Schulenburg JM, Kanavos P, Persson U, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:89-98
Péntek M, Gulácsi L, Brodszky V, Baji P, Boncz I, Pogány G, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Taruscio D, Iskrov G, Schieppati A, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and health-related quality of life in patients with fragile X syndrome in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:43-52
Chevreul K, Gandré C, Brigham KB, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Taruscio D, Schieppati A, Iskrov G, Gulácsi L, von der Schulenburg JM, Kanavos P, Persson U, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1:79-87
Kuhlmann A, Schmidt T, Treskova M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network.
PUBMED DOISocial/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. Eur J Health Econ. 2016 Apr;17 Suppl 1(Suppl 1):31-42
Angelis A, Kanavos P, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada de la Paz M, Taruscio D, Schieppati A, Iskrov G, Brodszky V, von der Schulenburg JM, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network.
PUBMED DOIInformación adicional
La Unidad de Modelos y Mecanismos tiene como objetivo la generación de modelos celulares para facilitar el diagnóstico de enfermedades raras complejas y estudiar los mecanismos moleculares responsables de la sintomatología de los pacientes. Entre otros modelos generamos células madre pluripotentes inducidas, también conocidas como iPSCs, a partir de células somáticas de pacientes con enfermedades raras que posteriormente diferenciamos a tipos celulares relevantes para estudiar la enfermedad, como por ejemplo neuronas. Nuestra unidad se centra especialmente (aunque no exclusivamente) en el estudio de enfermedades raras con base epigenética y en el uso de perfiles epigenéticos para mejorar el diagnóstico.